Optomed’s January–March 2020 interim report to be published on Friday 29 May 2020
Optomed Plc Press Release 27 May 2020 at 9.00, Helsinki
Optomed will publish its January–March 2020 interim report on Friday 29 May 2020 approximately at 9.00 EEST.
A telephone conference for analysts, investors and media will be arranged on the publishing day at 14.00 EEST. The event will be held in English. The presentation material will be available at www.optomed.com/investors 13.00 EEST at the latest. The participants are requested to register for the call in advance by email to firstname.lastname@example.org.
Please see the call-in numbers below:
FI +358 9 85626300
SE +46 8 505 218 52
UK +46 8 505 218 52
US +1 646-838-1719
The conference id is 920 394815#.
Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.
Sakari Knuutti, CLO, Optomed Plc, email@example.com, +358 50 562 4077
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 56 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.